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Abstract
Steryl glycosides produced by bacteria play important biological roles in the evasion and 
modulation of host immunity. Step economy syntheses of three cholesteryl-6-O-phosphatidyl-α-
D-glucopyranosides (αCPG) unique to H. pylori have been achieved. The approach relies upon 
regioselective C-6 deprotection of per-O-trimethylsilyl-α-D-cholesterylglucoside followed by 
phosphoramidite coupling. Global TMS ether deprotection in the presence of oxygen and 
subsequent deprotection of the cyano ethyl phosphoester afforded the target compounds in 
16-21% overall yield starting from D-glucose. The structures of these natural products were 
rigorously determined using a combination of 2D NMR methods and mass spectrometry. These 
robust synthesis and characterization protocols provide analogues to facilitate glycolipidomic 
profiling and biological studies.
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It has been 30 years since Marshall and Warren isolated and characterized H. pylori from 
patients with chronic gastritis.[1] Although the gram-negative bacterium infects half of the 
world population, most people are asymptomatic. However, patients who do show 
symptoms are left with a gambit of illnesses ranging from peptic ulcers to gastric 
carcinomas.[2] Extensive scientific efforts have contributed to understanding the role H. 
pylori plays in these illnesses. An area of research that continues to inform this pursuit is the 
synthesis and chemical characterization of the biomolecules produced by this pathogen.
Steryl glycosides are an intriguing class of bacterial derived immune modulators. Bacteria 
do not produce steroids and the mechanisms they use to confiscate cholesterol from the host 
are not well understood. Currently, the three known cholesteryl glucosides isolated from H. 
pylori are αCG (1), a C-6 analogue acylated with tetradecanoic acid (αCAG (2)), and a 
group of C-6 phosphorylated derivatives collectively referred to as αCPG (3) (Figure 
1).[2a, 2b, 3] The lipid portion on the phosphatidyl glycerol unit varies in composition as 
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identified from lyso-CPG analogues isolated from H. pylori.[2a, 2b, 3-4] Together, these α-
cholesteryl glucosides make up approximately 25% of the total lipid content of H. pylori and 
in other Helicobacter species can be as high as 33% of the total lipid content.[2a, 2b, 3]
To date, biological studies involving α-cholesteryl glucosides have mostly relied upon 
mixtures from natural sources making it difficult to determine the independent roles of each 
constituent.[2e, 2f] Moreover, biological studies have mainly relied upon TLC Rf values 
and/or mass spectrometry to characterize the components of the H. pylori glycolipid 
profile.[2a, 2b, 2f, 3-5] Recently, αCG (1) and αCAG (2) were synthesized and fully 
characterized by NMR and mass spectrometry making pure samples of these compounds 
available to the biological community for the first time.[6] The exact structures of naturally 
occurring αCPG analogues (3) have yet to be defined, as neither TLC nor MS can readily 
distinguish the diversity of isomers resulting from esterification of the phosphatidyl 
moiety.[2a, 2b, 3]
Given the growing importance of understanding the biological significance of H. pylori and 
related bacterial immunomodulators, a synthetic campaign focused on developing step 
economical syntheses of αCPG analogues (3a-c) was initiated. The target compounds are 
composed of three structural units including a cholesteryl aglycon, a sugar core, and a C-6 
phosphate ester with variable glycerol ester side chains, which together present several 
synthetic challenges including: (1) regioselective phosphorylation of the C6-hydroxyl[7] (2) 
avoidance of phosphite acetal formation as seen in previous research[8] (3) installment of the 
phosphatidyl group while avoiding acyl migration on the glycerol unit and (4) regioselective 
oxidation of phosphorus without oxidizing the double bond of cholesterol.[9] As highlighted 
in Figure 3, we envisioned beginning with per-O-TMS αCG (4)[10] because of its ready 
availability in two steps from glucose and its compatibility with the required criteria. 
Regioselective deprotection of the C-6 ether followed by condensation with an appropriate 
phosphoramidite would achieve the desired synthesis in a convergent manner.
Three different fatty acids are required to address the glycerol ester syntheses. Although 1,2-
dimyristoyl-sn-glycerol (5) and 1-palmitoyl-2-oleoyl-sn-glycerol (6) are commercially 
available, we wanted to establish a generalized synthesis of various diacyl glycerols for 
future library development. Thus studies began with esterification of 1-O-benzyl-sn-glycerol 
(7) using myristic acid in the presence of DCC and DMAP to afford 8 in 70% yield along 
with 23% of the di-addition product (9).[11] Compound 8 was then condensed a second time 
with oleic acid to form 10. Diacylglycerol 11 was synthesized by cyclopropanation of 10 via 
Simmons-Smith carbene formation utilizing Zn/Cu and diiodomethane (Scheme 1). 
Presumably this reaction proceeded to form a mixture of cyclopropyl diastereoisomers, 
which were not distinguishable by chromatography or NMR and thus no attempt was made 
to independently characterize the cyclopropyl isomers. The benzyl ether in compound 11 
was removed by hydrogenation to afford the desired glycerol 12, which was characterized 
by NMR.
A DEPT NMR experiment was utilized to identify the sn-213C (δ 70.6 ppm) and the 
corresponding 1H shift for the sn-2 C-H (δ 5.17 ppm) was assigned using HSQC NMR 
experiments. Afterwards, COSY NMR experiments revealed the 1H NMR shift for both the 
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sn-1 (δ 4.36 and 4.17 ppm) and sn-3 (δ 3.51 ppm) methylene protons. Likewise HMBC 
NMR experiments showed sn-1 CH2 correlation with the fatty ester carbonyl 13C (173.2 
ppm) thus distinguishing sn-1 from sn-3 (Figure 4).
The next step in the synthesis was conversion of commercially available 1-palmitoyl-2-
oleoyl-sn-glycerol to the phosphoramidite needed to couple to cholesteryl glucose. This was 
achieved by first activating 2-cyanoethyl N,N,N,’N’-tetraisopropylphosphordiamidite with 
tetrazole and displacing with 1-palmitoyl-2-oleoyl-sn-glycerol 6 to afford the glycerol-
phosphoramidite compound (14) in 92% yield as a 1:1 mixture of diastereomers (Scheme 
2).[12] The same strategy was utilized to prepare phosphoramidite 13 from 5[11a] and 15 
from 12 (Scheme 2).
Regioselective phosphatidylation at the C-6 position was initiated with the synthesis of 
compound 4, which was achievedusing our glycosyl iodide one pot glycosylation protocol 
starting from per-O-TMS glucose.[10] In this manner, we could generate per-O-silylated 
αCG (4) and then regioselectively desilylate the C-6 primary ether using ammonium acetate 
in dichloromethane and methanol to afford the free alcohol (16, Scheme 3).[13] The 
synthetic route to αCPG through compound 16 avoids phosphite acetal formation between 
the C4 and C6 hydroxyl of unprotected αCG(1) and any acyl migration event that could 
occur.[8] Freshly prepared phosphoramidites 13-15 were then coupled to 16 using tetrazole 
as the promoter (Scheme 3). Utilizing three molar equivalents of tetrazole was key to the 
success of the coupling reaction as any ratio less than 3 led to diminished yields (<10%). 
Even under these conditions, the yields were lower than desired presumably due to steric 
congestion about the phosphoramidite.[14] Subsequent introduction of O2 and DOWEX H+ 
resin achieved phosphorous oxidation with concomitant deprotection of the TMS ethers. 
Finally, the cyanoethyl protecting group was removed with 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU). After purificiation, αCPGs (3a-3c) were afforded in 16-21% yield starting from 
D-glucose (Scheme 3).
Extensive NMR analysis of the αCPG compounds revealed the phosphatidyl group to be on 
the C-6’ position of αCG. In the 13C NMR spectrum of 16, the C-6’ appears as a singlet at δ 
61.9 ppm (Table 1). After phosphatidylation with 13-15, the C-6’ shifts downfield and 
becomes a doublet due to phosphorous coupling (J=3.5-6.8 Hz). Also of note, the C-4’, 
C-3’, and C-2’ remain as singlets indicating the phosphate is not attached at these positions. 
After coupling with the phosphoramidites, a mixture of diastereomers (17-19) originating 
from the phosphorous is formed. The diastereomeric mixture is observed in the 31P NMR 
and in 13C NMR with C-3’, C-5’, C-6’, sn-1-C, sn-2-C, and sn-3-C carbon peaks appearing 
as duplicates. Different deuterated solvents were required to solubilize each sample for 
NMR investigations, which resulted in chemical shift fluctuations. Nevertheless, the 13C 
NMR shifts for 3a-3c were all quite similar. Furthermore, HMBC NMR experiments 
indicated the sn-2-CH and sn-1-CH2 from αCPG compounds 17-19 and 3a-3c were 
correlated with the carbonyl carbon of the corresponding fatty acids providing evidence that 
acyl migration did not occur and the phosphorous remained attached to the sn-3-CH2.
A synthetic protocol has been developed for making three different αCPG analogs (3a-c) 
associated with H. pylori immune modulation. Glycosylation of per-O-silylated glucose 
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proceeds efficiently and with high α-selectivity due to the armed nature of the per-O-silyl 
donors.[10] Selective deprotection of the primary ether and subsequent condensation with a 
highly functionalized phosphamidite followed by concomitant oxidation and deprotection 
afforded the desired analogs. Importantly, we have established a modular approach to 
preparing these natural products that is amenable to library development. The glycosyl 
iodide glycosylation is versatile allowing various cholesterol analogs as well as other lipids 
to be incorporated into different carbohydrate cores.[15] Likewise, we have demonstrated 
that the phosphoramidite chemistry is compatible with biologically relevant functional 
groups such as olefins and cyclopropanes. In light of the recent discovery that H. pylori 
enzymes are promiscuous and readily incorporate a variety of cholesterol analogs,[16] this 
modular platform offers accessibility to various phosphatidyl glycolipids not only to study 
their biological properties but to also aid in the discovery of new analogs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was supported by NIH R01GM090262, NSF CHE-0196482, NSF CRIF Program (CHE-9808183), and 
NSF OSTI 97-24412. Grants for 600 and 800MHz instruments include NSF DBIO 722538 and NIH PR1973. JGH 
gratefully acknowledges support from the National Science Foundation for independent research and development 
during her tenure as Divison Director of Chemistry.
References
1. Marshall B, Warren JR. The Lancet. 1984; 323:1311–1315.
2. a Hirai Y, Haque M, Yoshida T, Yokota K, Yasuda T, Oguma K. J.Bacteriol. 1995; 177:5327–5333. 
[PubMed: 7665522] b Haque M, Hirai Y, Yokota K, Mori N, Jahan I, Ito H, Hotta H, Yano I, 
Kanemasa Y, Oguma K. J.Bacteriol. 1996; 178:2065–2070. [PubMed: 8606185] c Peek RM Jr. 
Blaser MJ. Nat. Rev. Cancer. 2002; 2:28–37. [PubMed: 11902583] d Algood HM, Cover TL. 
Clinic. Microbiol. Rev. 2006; 19:597–613.e Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, 
Lindner B, Zahringer U, Mollenkopf HJ, Heinz E, Meyer TF. Nat. Med. 2006; 12:1030–1038. 
[PubMed: 16951684] f Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, 
Churin Y, Ignatius R, Meyer TF, Aebischer T. J. Infect. Dis. 2011; 204:1339–1348. [PubMed: 
21921201] g Park J, Forman D, Greenberg ER, Herrero R. Curr. Oncol. Rep. 2013; 15:517–525. 
[PubMed: 24101366] 
3. Haque M, Hirai Y, Yokota K, Oguma K, Bacteriol J. 1995; 177:5334–5337.
4. Lebrun A-H, Wunder C, Hildebrand J, Churin Y, Zähringer U, Lindner B, Meyer TF, Heinz E, 
Warnecke D. J. Biol. Chem. 2006; 281:27765–27772. [PubMed: 16844692] 
5. a Shimomura H, Hayashi S, Yokota K, Oguma K, Hirai Y. FEMS Microbiol. Lett. 2004; 237:407–
413. [PubMed: 15321690] b Wang H-J, Cheng W-C, Cheng H-H, Lai C-H, Wang W-C. Mol. 
Microbiol. 2012; 83:67–84. [PubMed: 22053852] c Ito Y, Vela JL, Matsumura F, Hoshino H, 
Tyznik A, Lee H, Girardi E, Zajonc DM, Liddington R, Kobayashi M, Bao XF, Bugaytsova J, 
Boren T, Jin RS, Zong YN, Seeberger PH, Nakayama J, Kronenberg M, Fukuda M. Plos One. 
2013:8.
6. Davis RA, Lin C-H, Gervay-Hague J. Chem. Commun. 2012; 48:9083–9085.
7. Abragam Joseph A, Chang C-W, Wang C-C. Chem. Commun. 2013; 49:11497–11499.
8. Patel MK, Davis BG. Org. Lett. 2013; 15:346–349. [PubMed: 23286302] 
9. a Yamada T, Imagawa K, Mukaiyama T. Chem. Lett. 1992; 21:2109–2112.b Salvador JAR, 
Silvestre SM, Moreira VM. Curr. Org. Chem. 2006; 10:2227–2257.
10. Davis RA, James C, Gervay-Hague J. J. Org. Chem. 2014 DOI:10.1021/jo501371h. 
Nguyen et al. Page 4













11. a Ioannou PV, Dodd GH, Golding BT. Synthesis-Stuttgart. 1979:939–941.b Greimel P, Ito Y. 
Tetrahedron Lett. 2008; 49:3562–3566.
12. Lin HJ, Adak AK, Reddy LVR, Wu SH, Lin CC. Chem. Eur. J. 2013; 19:7989–7998. [PubMed: 
23595956] 
13. Cui Y, Cheng Z, Mao J, Yu Y. Tetrahedron Lett. 2013; 54:3831–3833.
14. Wei X. Tetrahedron. 2013; 69:3615–3637.
15. Kulkarni SS, Gervay-Hague J. Org. Lett. 2008; 10:4739–4742. [PubMed: 18798644] 
16. Shimomura H, Hosoda K, McGee DJ, Hayashi S, Yokota K, Hirai Y. J. Bacteriol. 2013; 195:359–
367. [PubMed: 23144252] 
Nguyen et al. Page 5














Structures of H. pylori cholesteryl glucosides.
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Structures of H. pylori α-cholesteryl phosphatidyl glucosides.
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Retrosynthesis strategy for making H. pylori αCPG.
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NMR experiments utilized to determine ester locations.
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Synthesis of phosphoramidites 13-15.
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Table 1
13C NMR of 16-19, 3a-3c.
C-2′ (PPm) C-3′ (PPm) C-4′ (PPm) C-5′ (PPm) C-6′ (PPm)
16
[a] 74.2 75.1 72.4 73.0 61.0
17
[b] 71.8 73.9, 73.9 69.3 70.3, 70.2 67.5 (d, J = 5.4 Hz), 67.4 (d, J = 5.4 Hz)
18
[c] 75.9 74.4 72.1 72.8, 72.7 69.3 (d, J = 6.8 Hz)
19
[b] 72.5 74.4 70.3 71.1, 71.0 68.5 (d, J = 5.3 Hz), 68.3 (d, J = 3.5 Hz)
3a
[d] 72.4 73.4 69.2 71.6 (d, J = 3.2 Hz) 64.4 (d, J = 5.6 Hz)
3b
[e] 72.7 73.9 68.9 72.1 (d J = 2.6 Hz) 64.2 (d, J = 6.8 Hz)
3c
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